Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19

Background/Purpose: Coronavirus disease 2019 (COVID-19) is associated with increased risk of acute ischemic stroke (AIS), however, there is a paucity of data regarding outcomes after administration of intravenous tissue plasminogen activator (IV tPA) for stroke in patients with COVID-19. Methods: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Carneiro, Thiago, Dashkoff, Jonathan, Leung, Lester Y., Nobleza, Christa O'Hana S., Marulanda-Londono, Erika, Hathidara, Mausaminben, Koch, Sebastian, Sur, Nicole, Boske, Alexandra, Voetsch, Barbara, Aboul Nour, Hassan, Miller, Daniel J, Daneshmand, Ali, Shulman, Julie, Curiale, Gioacchino, Greer, David M., Romero, Jose Rafael, Anand, Pria, Cervantes-Arslanian, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383145/
https://www.ncbi.nlm.nih.gov/pubmed/33066885
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383145/
https://www.ncbi.nlm.nih.gov/pubmed/33066885
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105201

Ejemplares similares